ストックスクリーナーアプリを入手
3.51
2.23%
-0.08
Passage Bio Inc (PASG) 最新ニュース
EQUITY ALERT: The M&A Class Action Firm Is Investigating the Merger -- UTZ, SAFT, PASG and FNWDIS IT A FAIR DEAL FOR YOU? - PR Newswire
Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE - StreetInsider
PASG Stock Alert: Halper Sadeh LLC is Investigating Whether Passage Bio, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
Passage Bio amends merger terms: what it means for Passage Bio stock - AD HOC NEWS
$HAREHOLDER ALERT: IS IT A FAIR DEAL FOR YOU? The M&A Class Action Firm Is Investigating the Merger — UTZ, SAFT, PASG and FNWD - GlobeNewswire Inc.
Passage Bio outlines USD 100.0 million financing for Passage Bio stock - ad-hoc-news.de
About $100M in financing is expected for Passage Bio (PASG)'s Remix merger, dividing ownership three ways. - Stock Titan
How Low Will Passage (PASG) Go After -0.96% Sell-Off? 2026-09-29Merger Arbitrage - https://www.dars.gov.et/
CSR Stock Alert: Halper Sadeh LLC is Investigating Whether Centerspace is Obtaining a Fair Price for its Shareholders - Business Wire
Passage Bio stock gains 1.01 percent as Remix deal advances - AD HOC NEWS
Passage Bio stock holds steady as investors eye recent trial and cash runway - AD HOC NEWS
Passage Bio stock holds steady as investors eye recent trial and cash runway - ad-hoc-news.de
Passage Bio stock holds steady as investors weigh gene therapy pipeline and recent losses - ad-hoc-news.de
Passage Bio Amends Remix Merger, Private Financing Terms - TipRanks
Passage Bio Revises Remix Merger to Two-Step Structure, Adds $70 Million Pre-Funded PIPE - TradingView
[425] Passage BIO, Inc. Business Combination Communication | PASG SEC FilingForm 425 - Stock Titan
Remix deal would leave Passage Bio (NASDAQ: PASG) investors a small slice of the combined company - Stock Titan
Passage Bio stock reacts to reverse split as investors watch next steps - ad-hoc-news.de
Passage (PASG) Earnings Update: EPS Exceeds Its Estimate in the Latest Reading; Trading Move: Shares Fall 0.22% in the Current UpdateTech Earnings Analysis - vinanet.vn
Passage (PASG) Earnings Update: EPS Exceeds Its Estimate in the Latest Reading; Trading Move: Shares Fall 0.22% in the Current UpdateEarnings Season Outlook - dars.gov.et
GM1 Gangliosidosis Market Research Explores Growth Within A $0.95 Billion Opportunity - openPR.com
MDB Q2 2026 Earnings: EPS Beats Estimates by 10.06%, But Stock Slips 4.7%Consensus Miss Rate - dars.gov.et
Vestal Point Capital (PASG) filing shows no current Passage Bio share ownership - Stock Titan
Passage Bio | SCHEDULE 13G/A: Others - Moomoo
PASG Q2 2026 Earnings: Narrower-than-Expected Loss Drives 2% Share GainSpecial Dividend Alert - vinanet.vn
Passage Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Passage Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Passage Bio Q2 Results: EPS beats estimates, losses narrow YoY - scanx.trade
Passage Bio Q2 net loss narrows 16.67% to $7.82 million - Bitget
Passage Bio Q2 net loss narrows 16.67% to $7.82 million - Bitget
Passage BIO, Inc. 2026: Revenue ($7.82M), Net income ($7.82M), EPS ($2.44) — 10-Q Summary - TradingView
PASG: Pending merger with Remix is vital as cash dwindles and operations wind down - TradingView
Passage Bio (PASG) outlines Q2 2026 loss, cash strain and Remix merger terms - Stock Titan
Passage Bio Inc expected to post a loss of $2.65 a shareEarnings Preview - TradingView
Passage Bio Inc (PASG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CYBR.O Forecast — Price Prediction for 2026. Should I Buy CYBR.O? - Intellectia AI
Emerging Sub-Segments Transforming the Lysosomal Enzyme Market Landscape - openPR.com
REPX Q1 2026 Earnings: Deep EPS Miss Delivers -369.75% Surprise as Shares Gain 2.24%Revenue Breakdown Analysis - vinanet.vn
PASG Q2'26 Earnings: EPS estimate is (2.65) USD - TradingView
Passage Bio Inc. (PASG) Slips 3% as Shares Approach Key Support LevelRSI Overbought Alerts - vinanet.vn
Passage Bio Inc (PASG) Cash Flow - TradingKey
Passage Bio Inc (PASG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Passage Bio Inc (PASG) Institutional Confidence - TradingKey
Passage Bio Inc (PASG) Income Statement - tradingkey.com
Passage Bio Inc (PASG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Passage Bio Inc (PASG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Passage Bio Inc (PASG) Balance Sheet - TradingKey
PASG|Passage Bio Inc|Price:4.570|Chg%:-0.370 - TradingKey
PASG|Passage Bio Inc|Price:4.940|Chg%:+0.040 - TradingKey
Passage Bio Inc (PASG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
0.68%
3.98%
大文字化:
|
ボリューム (24 時間):